UKAS has undertaken pilot assessments under its Medical Physics and Clinical Engineering (MPACE) scheme in the areas of Radiotherapy Physics and Clinical Engineering against the requirements of BS 70000. In discussion with the MPACE Technical Advisory Committee, British Nuclear Medicine Society (BNMS) and IPEM, UKAS is now looking to extend the scheme into the area of Nuclear Medicine. A call for expression of interests can be found on the following UKAS website
To all BNMS Members,
We want to thank you for your continued support.
Your membership has allowed us to achieve so much this year
Congratulations to our New President Elect, Dr Richard Graham of Royal United Hospital, Bath.
The announcement was made at the BNMS AGM on Tuesday 2nd April 2019 in Oxford.
Dr Graham will officially become the BNMS President at the next AGM in Liverpool in 2020.
The BNMS are pleased to announce the Travelling Fellowship Award 2017 has been awarded to Dr Amit Parekh of Southmead Hospital, Bristol.
The society has agreed to award £1000 to support a two week observorship at the Memorial S19oan Ketting Cancer Centre in New York, USA.
The British Nuclear Medicine Society has worked with the Royal College of Radiologists and the UK Radiopharmacy Group to produce practical guidance to help nuclear medicine teams plan radioisotope work in case of a no-deal Brexit.
Practical advice for radiopharmacy and nuclear medicine services in the event of a no-deal Brexit outlines industry updates on supplier preparedness for tracer and therapeutic radioisotope supply in the event of no-deal, and urges clinicians to liaise directly with their suppliers for information on individual products.
It contains advice to help services produce individual risk assessments, emphasising the importance of communication and supply networking between hospitals.
The guidance contains practical advice on procurement changes and considerations for workload planning and case prioritisation depending on supply alterations.
The planning document also lists product alternatives and substitutions for particular imaging procedures, as well as key considerations for oncology teams faced with irregular supply.